Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 12;60(29):16119-16128.
doi: 10.1002/anie.202104228. Epub 2021 Jun 10.

Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity

Affiliations

Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity

Lucia Furiassi et al. Angew Chem Int Ed Engl. .

Abstract

Structurally complex natural products have been a fruitful source for the discovery and development of new drugs. In an effort to construct a compound collection populated by architecturally complex members with unique scaffolds, we have used the natural product limonin as a starting point. Limonin is an abundant triterpenoid natural product and, through alteration of its heptacyclic core ring system using short synthetic sequences, a collection of 98 compounds was created, including multiple members with novel ring systems. The reactions leveraged in the construction of these compounds include novel ring cleavage, rearrangements, and cyclizations, and this work is highlighted by the discovery of a novel B-ring cleavage reaction, a unique B/C-ring rearrangement, an atypical D-ring cyclization, among others. Computational analysis shows that 52 different scaffolds/ring systems were produced during the course of this work, of which 36 are unprecedented. Phenotypic screening and structure-activity relationships identified compounds with activity against a panel of cancer cell lines.

Keywords: anticancer agents; drug discovery; limonin; natural products; scaffold diversity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scaffold collection derived from limonin (1).
Figure 2.
Figure 2.
Biological evaluation of key compounds against cancer cells in culture. Bioactivity is expressed as a 72-hour IC50 value (in μM) against a panel of cell lines, as measured by Alamar Blue assay. Data represent mean ± SEM, Raptinal (50 μM) was used as dead control, n = 3 biological replicates; [a] number of steps from limonin, [b] not soluble at 100 μM.
Scheme 1.
Scheme 1.
Overview of the scaffolds generated from the triterpenoid limonin.
Scheme 2.
Scheme 2.
Limonin B-ring expansion, E-ring opening, and further manipulations of the A and B rings.
Scheme 3.
Scheme 3.
Synthesis and functionalization of the ring-opened derivatives 10 and 11.
Scheme 4.
Scheme 4.
Rearrangement of the B and C rings of limonol (3).
Scheme 5.
Scheme 5.
Manipulation of the ring-rearranged derivative 4.
Scheme 6.
Scheme 6.
Manipulation of the D-ring cleaved derivative 5.

Similar articles

Cited by

References

    1. Brown DG, Bostrom J, J. Med. Chem 2018, 61, 9442–9468. - PubMed
    1. Macarron R, Banks M, Bojanic D, Burns D, Cirovic D, Garyantes T, Green D, Hertzberg R, Janzen W, Paslay J, Schopfer U, Sittampalam G, Nat. Rev. Drug Discov 2011, 10, 188–195. - PubMed
    1. Stratton CF, Newman DJ, Tan DS, Bioorg. Med. Chem. Lett 2015, 25, 4802–4807. - PMC - PubMed
    1. Lovering F, Bikker J, Humblet C, J. Med. Chem 2009, 52, 6752–6756. - PubMed
    1. Tajabadi FM, Campitelli MR, Quinn RJ, Springer Sci. Rev 2013, 1, 141–151.

MeSH terms